Billing Codes

61612

Whole body FDG PET study for the initial staging of cancer, for a patient who is considered suitable for active therapy, if:(a) the cancer is a typically FDG-avid cancer; and(b) there is at least 10% likelihood that a PET study result will inform a significant change in management for the patientApplicable once per cancer diagnosis (R)

Schedule fee
$953.00
was $953.00
100% Benefit
85%: $848.50
75%: $714.75
Category
Category 5 — Diagnostic Imaging
Group I4
Status
Unchanged
Full description

Whole body FDG PET study for the initial staging of cancer, for a patient who is considered suitable for active therapy, if:(a) the cancer is a typically FDG-avid cancer; and(b) there is at least 10% likelihood that a PET study result will inform a significant change in management for the patientApplicable once per cancer diagnosis (R)

Fee history

No recorded changes yet — history accumulates with each release.

Data sourced from Australian Government publications · Not an official government service